- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alivus Life Sciences reports Q3 financial results: Revenue from operations hit ₹672.89 Cr, with a profit of ₹150.26 Cr. For the nine months ending Dec 31, 2025, revenue reached ₹1862.72 Cr and profit stood at ₹401.82 Cr.